Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
1.130
-0.030 (-2.59%)
At close: Dec 5, 2025, 4:00 PM EST
1.122
-0.008 (-0.74%)
After-hours: Dec 5, 2025, 7:58 PM EST
Pasithea Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 4.12 | 6.92 | 16.33 | 33.09 | 52.97 | 0.24 |
| Cash & Short-Term Investments | 4.12 | 6.92 | 16.33 | 33.09 | 52.97 | 0.24 |
| Cash Growth | -55.96% | -57.61% | -50.64% | -37.53% | 21638.85% | - |
| Other Receivables | - | - | 0.04 | - | - | - |
| Receivables | - | - | 0.04 | - | - | - |
| Prepaid Expenses | 1.29 | 0.3 | 0.22 | 0.56 | 0.33 | 0 |
| Other Current Assets | 0.02 | 0.14 | 0.1 | 0.43 | - | - |
| Total Current Assets | 5.53 | 7.37 | 16.69 | 34.08 | 53.3 | 0.25 |
| Property, Plant & Equipment | - | 0.12 | 0.22 | 0.63 | 0.02 | - |
| Goodwill | 1.26 | 1.26 | 1.26 | 1.26 | - | - |
| Other Intangible Assets | 6.84 | 7.31 | 7.94 | 8.57 | - | - |
| Other Long-Term Assets | - | - | - | 0.64 | - | - |
| Accounts Payable | 1.34 | 1.12 | 2.55 | 1.48 | 0.45 | 0.01 |
| Current Portion of Leases | - | - | 0.08 | 0.16 | - | - |
| Other Current Liabilities | 0.04 | - | - | 0.24 | - | - |
| Total Current Liabilities | 1.38 | 1.12 | 2.63 | 1.88 | 0.45 | 0.01 |
| Long-Term Leases | - | - | - | 0.34 | - | - |
| Other Long-Term Liabilities | 0.05 | 0.16 | 0.08 | 0.46 | 1.45 | - |
| Common Stock | 0 | 0 | 0 | 0 | 0.02 | 0.01 |
| Additional Paid-In Capital | 72.09 | 64.37 | 58.72 | 61.86 | 53.63 | 0.27 |
| Retained Earnings | -59.9 | -49.58 | -35.32 | -19.36 | -2.21 | -0.04 |
| Comprehensive Income & Other | 0.02 | -0.01 | -0 | -0 | -0.01 | - |
| Total Liabilities & Equity | 13.63 | 16.06 | 26.12 | 45.18 | 53.32 | 0.25 |
| Total Debt | - | - | 0.08 | 0.5 | - | - |
| Net Cash (Debt) | 4.12 | 6.92 | 16.25 | 32.58 | 52.97 | 0.24 |
| Net Cash Growth | -55.96% | -57.40% | -50.13% | -38.48% | 21638.85% | - |
| Net Cash Per Share | 0.99 | 6.32 | 13.25 | 25.81 | 101.81 | 0.66 |
| Filing Date Shares Outstanding | 7.44 | 2.71 | 1.04 | 1.31 | 1.14 | 0.42 |
| Total Common Shares Outstanding | 7.44 | 1.39 | 1.04 | 1.3 | 1.15 | 0.37 |
| Working Capital | 4.15 | 6.25 | 14.06 | 32.2 | 52.85 | 0.24 |
| Book Value Per Share | 1.64 | 10.60 | 22.46 | 32.64 | 44.70 | 0.65 |
| Tangible Book Value | 4.11 | 6.21 | 14.19 | 32.66 | 51.42 | 0.24 |
| Tangible Book Value Per Share | 0.55 | 4.45 | 13.63 | 25.08 | 44.70 | 0.65 |
| Machinery | - | 0.16 | 0.16 | 0.13 | 0.02 | - |
| Leasehold Improvements | - | 0 | 0 | 0 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.